• News Releases
  • Oct. 08, 2020 (PDF/169KB)Corporate
    Sumitomo Chemical and Sumitomo Dainippon Pharma Announce Establishment and Inception of Operations of a Joint Venture Company for CDMO Business in the field of Regenerative Medicine and Cell Therapy
  • Oct. 08, 2020 (PDF/29KB)Corporate
    Urovant Sciences Announces Co-Promotion Agreement for Vibegron with Sunovion Pharmaceuticals
  • Oct. 06, 2020 (PDF/275KB)Products
    Sunovion Announces the Commercial Launch of KYNMOBI (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson's Disease OFF Episodes
  • Sep. 30, 2020 (PDF/98KB)R&D
    Myovant Sciences Announces Results of Additional Secondary Endpoint of Castration Resistance-Free Survival from Phase 3 HERO Study of Relugolix in Advanced Prostate Cancer
  • Sep. 23, 2020 (PDF/98KB)Corporate
    Sumitomo Dainippon Pharma Establishes a Subsidiary in Taiwan